Subsequently, our results from luciferase reporter assays involving SOX2 promoter and its mutant as well as ChIP assays further confirmed the direct binding between TAZ/TEAD4 and SOX2 promoter in HNSCC. Here, SOX2 is linked to head and neck squamous cell carcinoma.